Figure 11.
Biodistribution of DOX-SPIOs in tumor and liver tissue following combination therapy (nano-embolization followed by nano-ablation) in VX2 rabbit model. Combination therapy resulted in significantly increased delivery to both the tumor core and periphery, compared to nano-embolization alone (p<0.05). Furthermore, a significant difference in off-target delivery, to healthy liver tissue, was not observed (p=ns).